The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Point-of-Care Genetic Testing Market Research Report 2025

Global Point-of-Care Genetic Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1979704

No of Pages : 76

Synopsis
Point-of-care genetic testing identifies variations in the genetic sequence at the bedside – enabling clinicians to react and alter therapy based upon the results.
The global Point-of-Care Genetic Testing market was valued at US$ 6303.8 million in 2023 and is anticipated to reach US$ 7584.5 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
North American market for Point-of-Care Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Point-of-Care Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Point-of-Care Genetic Testing in Diagnostic Labs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Point-of-Care Genetic Testing include Abbott (US), Roche (Switzerland), Thermo Fisher Scientific (US), Cepheid (US), IQuum (US), Biocartis (Switzerland), Idaho Technologies (US), Optigene (UK) and Lumora (UK), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Genetic Testing.
Report Scope
The Point-of-Care Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-of-Care Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-of-Care Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott (US)
Roche (Switzerland)
Thermo Fisher Scientific (US)
Cepheid (US)
IQuum (US)
Biocartis (Switzerland)
Idaho Technologies (US)
Optigene (UK)
Lumora (UK)
Segment by Type
POCT Cancer Kits
Molecular POC Kits
POCT In Antibiotic Therapies
Assay Cartridge
Other
Segment by Application
Diagnostic Labs
Bio-Pharmaceutical Industry
Academic Institutions
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-Care Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-Care Genetic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 POCT Cancer Kits
1.2.3 Molecular POC Kits
1.2.4 POCT In Antibiotic Therapies
1.2.5 Assay Cartridge
1.2.6 Other
1.3 Market by Application
1.3.1 Global Point-of-Care Genetic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Labs
1.3.3 Bio-Pharmaceutical Industry
1.3.4 Academic Institutions
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-Care Genetic Testing Market Perspective (2019-2030)
2.2 Point-of-Care Genetic Testing Growth Trends by Region
2.2.1 Global Point-of-Care Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Point-of-Care Genetic Testing Historic Market Size by Region (2019-2024)
2.2.3 Point-of-Care Genetic Testing Forecasted Market Size by Region (2025-2030)
2.3 Point-of-Care Genetic Testing Market Dynamics
2.3.1 Point-of-Care Genetic Testing Industry Trends
2.3.2 Point-of-Care Genetic Testing Market Drivers
2.3.3 Point-of-Care Genetic Testing Market Challenges
2.3.4 Point-of-Care Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Genetic Testing Players by Revenue
3.1.1 Global Top Point-of-Care Genetic Testing Players by Revenue (2019-2024)
3.1.2 Global Point-of-Care Genetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Point-of-Care Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-Care Genetic Testing Revenue
3.4 Global Point-of-Care Genetic Testing Market Concentration Ratio
3.4.1 Global Point-of-Care Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Genetic Testing Revenue in 2023
3.5 Point-of-Care Genetic Testing Key Players Head office and Area Served
3.6 Key Players Point-of-Care Genetic Testing Product Solution and Service
3.7 Date of Enter into Point-of-Care Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Genetic Testing Breakdown Data by Type
4.1 Global Point-of-Care Genetic Testing Historic Market Size by Type (2019-2024)
4.2 Global Point-of-Care Genetic Testing Forecasted Market Size by Type (2025-2030)
5 Point-of-Care Genetic Testing Breakdown Data by Application
5.1 Global Point-of-Care Genetic Testing Historic Market Size by Application (2019-2024)
5.2 Global Point-of-Care Genetic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Point-of-Care Genetic Testing Market Size (2019-2030)
6.2 North America Point-of-Care Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Point-of-Care Genetic Testing Market Size by Country (2019-2024)
6.4 North America Point-of-Care Genetic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-Care Genetic Testing Market Size (2019-2030)
7.2 Europe Point-of-Care Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Point-of-Care Genetic Testing Market Size by Country (2019-2024)
7.4 Europe Point-of-Care Genetic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-Care Genetic Testing Market Size (2019-2030)
8.2 Asia-Pacific Point-of-Care Genetic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Point-of-Care Genetic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Point-of-Care Genetic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-Care Genetic Testing Market Size (2019-2030)
9.2 Latin America Point-of-Care Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Point-of-Care Genetic Testing Market Size by Country (2019-2024)
9.4 Latin America Point-of-Care Genetic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-Care Genetic Testing Market Size (2019-2030)
10.2 Middle East & Africa Point-of-Care Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Point-of-Care Genetic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Point-of-Care Genetic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott (US)
11.1.1 Abbott (US) Company Detail
11.1.2 Abbott (US) Business Overview
11.1.3 Abbott (US) Point-of-Care Genetic Testing Introduction
11.1.4 Abbott (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024)
11.1.5 Abbott (US) Recent Development
11.2 Roche (Switzerland)
11.2.1 Roche (Switzerland) Company Detail
11.2.2 Roche (Switzerland) Business Overview
11.2.3 Roche (Switzerland) Point-of-Care Genetic Testing Introduction
11.2.4 Roche (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2019-2024)
11.2.5 Roche (Switzerland) Recent Development
11.3 Thermo Fisher Scientific (US)
11.3.1 Thermo Fisher Scientific (US) Company Detail
11.3.2 Thermo Fisher Scientific (US) Business Overview
11.3.3 Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Introduction
11.3.4 Thermo Fisher Scientific (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024)
11.3.5 Thermo Fisher Scientific (US) Recent Development
11.4 Cepheid (US)
11.4.1 Cepheid (US) Company Detail
11.4.2 Cepheid (US) Business Overview
11.4.3 Cepheid (US) Point-of-Care Genetic Testing Introduction
11.4.4 Cepheid (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024)
11.4.5 Cepheid (US) Recent Development
11.5 IQuum (US)
11.5.1 IQuum (US) Company Detail
11.5.2 IQuum (US) Business Overview
11.5.3 IQuum (US) Point-of-Care Genetic Testing Introduction
11.5.4 IQuum (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024)
11.5.5 IQuum (US) Recent Development
11.6 Biocartis (Switzerland)
11.6.1 Biocartis (Switzerland) Company Detail
11.6.2 Biocartis (Switzerland) Business Overview
11.6.3 Biocartis (Switzerland) Point-of-Care Genetic Testing Introduction
11.6.4 Biocartis (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2019-2024)
11.6.5 Biocartis (Switzerland) Recent Development
11.7 Idaho Technologies (US)
11.7.1 Idaho Technologies (US) Company Detail
11.7.2 Idaho Technologies (US) Business Overview
11.7.3 Idaho Technologies (US) Point-of-Care Genetic Testing Introduction
11.7.4 Idaho Technologies (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024)
11.7.5 Idaho Technologies (US) Recent Development
11.8 Optigene (UK)
11.8.1 Optigene (UK) Company Detail
11.8.2 Optigene (UK) Business Overview
11.8.3 Optigene (UK) Point-of-Care Genetic Testing Introduction
11.8.4 Optigene (UK) Revenue in Point-of-Care Genetic Testing Business (2019-2024)
11.8.5 Optigene (UK) Recent Development
11.9 Lumora (UK)
11.9.1 Lumora (UK) Company Detail
11.9.2 Lumora (UK) Business Overview
11.9.3 Lumora (UK) Point-of-Care Genetic Testing Introduction
11.9.4 Lumora (UK) Revenue in Point-of-Care Genetic Testing Business (2019-2024)
11.9.5 Lumora (UK) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Point-of-Care Genetic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of POCT Cancer Kits
Table 3. Key Players of Molecular POC Kits
Table 4. Key Players of POCT In Antibiotic Therapies
Table 5. Key Players of Assay Cartridge
Table 6. Key Players of Other
Table 7. Global Point-of-Care Genetic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Point-of-Care Genetic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Point-of-Care Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Point-of-Care Genetic Testing Market Share by Region (2019-2024)
Table 11. Global Point-of-Care Genetic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Point-of-Care Genetic Testing Market Share by Region (2025-2030)
Table 13. Point-of-Care Genetic Testing Market Trends
Table 14. Point-of-Care Genetic Testing Market Drivers
Table 15. Point-of-Care Genetic Testing Market Challenges
Table 16. Point-of-Care Genetic Testing Market Restraints
Table 17. Global Point-of-Care Genetic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Point-of-Care Genetic Testing Market Share by Players (2019-2024)
Table 19. Global Top Point-of-Care Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Genetic Testing as of 2023)
Table 20. Ranking of Global Top Point-of-Care Genetic Testing Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Point-of-Care Genetic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Point-of-Care Genetic Testing Product Solution and Service
Table 24. Date of Enter into Point-of-Care Genetic Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Point-of-Care Genetic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Point-of-Care Genetic Testing Revenue Market Share by Type (2019-2024)
Table 28. Global Point-of-Care Genetic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Point-of-Care Genetic Testing Revenue Market Share by Type (2025-2030)
Table 30. Global Point-of-Care Genetic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Point-of-Care Genetic Testing Revenue Market Share by Application (2019-2024)
Table 32. Global Point-of-Care Genetic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Point-of-Care Genetic Testing Revenue Market Share by Application (2025-2030)
Table 34. North America Point-of-Care Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Point-of-Care Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Point-of-Care Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Point-of-Care Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Point-of-Care Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Point-of-Care Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Point-of-Care Genetic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Point-of-Care Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Point-of-Care Genetic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Point-of-Care Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Point-of-Care Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Point-of-Care Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Point-of-Care Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Point-of-Care Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Point-of-Care Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 49. Abbott (US) Company Detail
Table 50. Abbott (US) Business Overview
Table 51. Abbott (US) Point-of-Care Genetic Testing Product
Table 52. Abbott (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024) & (US$ Million)
Table 53. Abbott (US) Recent Development
Table 54. Roche (Switzerland) Company Detail
Table 55. Roche (Switzerland) Business Overview
Table 56. Roche (Switzerland) Point-of-Care Genetic Testing Product
Table 57. Roche (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2019-2024) & (US$ Million)
Table 58. Roche (Switzerland) Recent Development
Table 59. Thermo Fisher Scientific (US) Company Detail
Table 60. Thermo Fisher Scientific (US) Business Overview
Table 61. Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Product
Table 62. Thermo Fisher Scientific (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024) & (US$ Million)
Table 63. Thermo Fisher Scientific (US) Recent Development
Table 64. Cepheid (US) Company Detail
Table 65. Cepheid (US) Business Overview
Table 66. Cepheid (US) Point-of-Care Genetic Testing Product
Table 67. Cepheid (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024) & (US$ Million)
Table 68. Cepheid (US) Recent Development
Table 69. IQuum (US) Company Detail
Table 70. IQuum (US) Business Overview
Table 71. IQuum (US) Point-of-Care Genetic Testing Product
Table 72. IQuum (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024) & (US$ Million)
Table 73. IQuum (US) Recent Development
Table 74. Biocartis (Switzerland) Company Detail
Table 75. Biocartis (Switzerland) Business Overview
Table 76. Biocartis (Switzerland) Point-of-Care Genetic Testing Product
Table 77. Biocartis (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2019-2024) & (US$ Million)
Table 78. Biocartis (Switzerland) Recent Development
Table 79. Idaho Technologies (US) Company Detail
Table 80. Idaho Technologies (US) Business Overview
Table 81. Idaho Technologies (US) Point-of-Care Genetic Testing Product
Table 82. Idaho Technologies (US) Revenue in Point-of-Care Genetic Testing Business (2019-2024) & (US$ Million)
Table 83. Idaho Technologies (US) Recent Development
Table 84. Optigene (UK) Company Detail
Table 85. Optigene (UK) Business Overview
Table 86. Optigene (UK) Point-of-Care Genetic Testing Product
Table 87. Optigene (UK) Revenue in Point-of-Care Genetic Testing Business (2019-2024) & (US$ Million)
Table 88. Optigene (UK) Recent Development
Table 89. Lumora (UK) Company Detail
Table 90. Lumora (UK) Business Overview
Table 91. Lumora (UK) Point-of-Care Genetic Testing Product
Table 92. Lumora (UK) Revenue in Point-of-Care Genetic Testing Business (2019-2024) & (US$ Million)
Table 93. Lumora (UK) Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-Care Genetic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Point-of-Care Genetic Testing Market Share by Type: 2023 VS 2030
Figure 3. POCT Cancer Kits Features
Figure 4. Molecular POC Kits Features
Figure 5. POCT In Antibiotic Therapies Features
Figure 6. Assay Cartridge Features
Figure 7. Other Features
Figure 8. Global Point-of-Care Genetic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Point-of-Care Genetic Testing Market Share by Application: 2023 VS 2030
Figure 10. Diagnostic Labs Case Studies
Figure 11. Bio-Pharmaceutical Industry Case Studies
Figure 12. Academic Institutions Case Studies
Figure 13. Other Case Studies
Figure 14. Point-of-Care Genetic Testing Report Years Considered
Figure 15. Global Point-of-Care Genetic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Point-of-Care Genetic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Point-of-Care Genetic Testing Market Share by Region: 2023 VS 2030
Figure 18. Global Point-of-Care Genetic Testing Market Share by Players in 2023
Figure 19. Global Top Point-of-Care Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Genetic Testing as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Point-of-Care Genetic Testing Revenue in 2023
Figure 21. North America Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Point-of-Care Genetic Testing Market Share by Country (2019-2030)
Figure 23. United States Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Point-of-Care Genetic Testing Market Share by Country (2019-2030)
Figure 27. Germany Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Point-of-Care Genetic Testing Market Share by Region (2019-2030)
Figure 35. China Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Point-of-Care Genetic Testing Market Share by Country (2019-2030)
Figure 43. Mexico Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Point-of-Care Genetic Testing Market Share by Country (2019-2030)
Figure 47. Turkey Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Point-of-Care Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Abbott (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2019-2024)
Figure 50. Roche (Switzerland) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2019-2024)
Figure 51. Thermo Fisher Scientific (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2019-2024)
Figure 52. Cepheid (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2019-2024)
Figure 53. IQuum (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2019-2024)
Figure 54. Biocartis (Switzerland) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2019-2024)
Figure 55. Idaho Technologies (US) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2019-2024)
Figure 56. Optigene (UK) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2019-2024)
Figure 57. Lumora (UK) Revenue Growth Rate in Point-of-Care Genetic Testing Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’